Peer review Peer review information Nature Communications thanks Julie Sheldon and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Key points: Wegovy is a more effective weight-loss medication Wegovy is more expensive than Orlistat and has a slightly worse safety profile But, both medications are generally well-tolerated Whether you choose Wegovy or Orlistat will depend on many factors, such as affordability and your response to the medications Take home message The recent innovations in GLP-1 medications are pretty remarkable and have caused quite a stir in the world of healthcare
Each handoff is a point where transparency and licensure matter, and a strong operator makes that chain visible rather than opaque
#NovoNordisk #Ozempic #Semaglutide #GLP1 #Type2Diabetes #Obesity #AccessToMedicine #HealthcareInnovation #Pharma #EmergingMarkets Novo Nordisks launch of Extensior in South Africa is a smart, strategically timed move that tackles two challenges at once: affordability barriers and the rapid rise of greymarket semaglutide
The pill, like injectable Wegovy and Ozempic for diabetes, has the active ingredient semaglutide
